 IONIS-GCCRRx

IONIS-GCCRRx, also known as ISIS-426115, is an antiglucocorticoid which is under development by Ionis Pharmaceuticals (formerly Isis Pharmaceuticals) for the treatment of diabetes mellitus type 2.It has also been under investigation for the treatment of Cushing's syndrome, but no development has been reported.